search icon
  • What's New in Practice Management & Payment

    AMA Releases an Interactive Web-based Tool for MIPS

    CMS Releases 2018 Medicare Physician Fee Schedule Proposed Rule

    CMS: Fact Sheet for the QPP Year 2 Proposed Rule

    AMA Releases New MIPS Resources

    CMS Releases Lookup Tool to Help Clinicians Determine their MIPS Participation Status

  • News from IDSA and Journals


    JID Supplement Explores Careers in Infectious Diseases


    A new journal supplement examines career opportunities in ID, workforce challenges, and strategies to move forward, including personal reflections on diverse career paths in the field.

  • CDC and FDA Alerts

    9/18/2017 2:25:23 PM

    FDA approves new drug for bacterial vaginosis

    Today FDA approved a new medication for bacterial vaginosis. This treatment is the first one-dose oral regimen for the most common vaginal infection in women 15-44 years of age.

    9/13/2017 4:53:22 PM

    Rifampin/Penicillin-Resistant Strain of RB51 Brucella Contracted from Consumption of Raw Milk

    The Texas Department of State Health Services, with assistance from CDC, is investigating Brucella RB51 exposures and illnesses that may be connected to the purchase and consumption of raw (unpasteurized) milk from K-Bar Dairy in Paradise, Texas.

    9/12/2017 3:15:14 PM

    Tetanus in Areas Affected by a Hurricane: Risk, Prevention, and Management Guidelines for Clinicians

    Exposure to flood waters does not increase the risk of tetanus. Therefore, tetanus immunization campaigns for evacuees from flooding disasters are not needed. 

    9/12/2017 11:49:08 AM

    Hurricane Irma—Clinical Guidance for Carbon Monoxide (CO) Poisoning

    Hurricane Irma, one of the largest hurricanes in history, caused an over 7.7 million households to lose power.

    9/12/2017 11:37:18 AM

    Hurricane Harvey—Clinical Guidance for Carbon Monoxide (CO) Poisoning

    Carbon monoxide (CO) is an odorless, colorless, poisonous gas that can cause sudden illness and death if present in sufficient concentration in the ambient air. 

    8/31/2017 10:25:43 AM

    FDA approves first U.S. treatment for Chagas disease - Drug Information Update

    The U.S. Food and Drug Administration granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease. It is the first treatment approved in the United States for the treatment of Chagas disease..

    8/30/2017 1:35:54 PM

    FDA approves new antibacterial drug - Drug Information Update

    The U.S. Food and Drug Administration approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria. 

    8/7/2017 5:39:15 PM

    Increase in Reported cases of Cyclospora cayetanensis Infection, United States, Summer 2017

    The Centers for Disease Control and Prevention (CDC), State and Local Health Departments, and theFood and Drug Administration (FDA) are investigating an increase in reported cases of cyclosporiasis.

| HIVMA | Contact Us

© Copyright IDSA 2017 Infectious Diseases Society of America

Full Site Mobile Site